| Financial Year |
March 31 2023 |
| Monetary Funds |
249,557,422.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
100,000.00 |
| Accounts Receivable |
31,245,338.31 |
| Advances to Suppliers |
42,371,305.39 |
| Other Receivables |
8,851,320.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
125,654,535.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,826,199.45 |
| Total Current Assets |
463,606,121.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
277,269,083.21 |
| Under-construction Projects |
138,613.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,847,495.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
133,983.37 |
| Deferred Income Tax Assets |
764,568.10 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
284,153,744.00 |
| Total Assets |
747,759,865.77 |
| Short-Term Loans |
2,002,230.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
35,013,844.63 |
| Accounts Received In Advance |
1,278,750.59 |
| Employee Compensation Payable |
20,572,906.60 |
| Taxes Payable |
2,314,414.40 |
| Interest Payable |
32,150,358.32 |
| Dividend Payable |
2,027,501.41 |
| Other payables |
401,353,573.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
230,554.20 |
| Other Current Liabilities |
1,717,655.95 |
| Sub-Total of Current Liabilities |
486,013,968.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
125,665,271.63 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
144,470,033.78 |
| Total Liabilities |
630,484,002.22 |
| Paid-In Capital(Or Share Stock) |
771,283,579.00 |
| Capital Surplus |
1,071,565,288.52 |
| Surplus Reserve |
87,429,291.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,767,177,601.07 |
| Minority Stockholder's Interest |
5,079,199.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
112,196,664.15 |
| Owner's Equity（Stockholder's Equity） |
117,275,863.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
747,759,865.77 |
